NCT07689461 VR Effects After Hip Replacement Surgery Pain
| NCT ID | NCT07689461 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adiyaman University |
| Condition | Virtual Reality |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-10-21 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-10-21 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total Hip Arthroplasty (THA), a procedure performed to enhance the quality of life, is accompanied by postoperative challenges such as pain and anxiety that adversely affect patient comfort. Inadequate management of these complications can prolong the length of hospital stay, delay recovery, lead to functional impairments, and elevate the risk of chronic pain development. Conventional pharmacological interventions employed for management are limited due to their potential for adverse effects and dependency. Virtual reality (VR) is a non-pharmacological distraction technique utilized in the healthcare sector, leveraging advanced technology to maximize patient comfort by alleviating pain and minimizing anxiety. A review of the literature reveals that while the use of VR has positive effects on pain and anxiety, there is a notable scarcity of high-quality randomized controlled trials concurrently evaluating its impact on pain, anxiety, and comfort levels in postoperative orthopedic procedures such as THA. In this randomized controlled trial, participants in the control group will receive standard care, whereas those in the experimental group will receive a 30-minute VR intervention-offering three distinct options-in addition to standard care during the acute phase of the first 48 hours. Postoperative assessments will be conducted using the Visual Analogue Scale (VAS) for pain intensity, the State Anxiety Inventory for anxiety levels, and the Perianesthesia Comfort Scale for comfort levels. By evaluating the potential of VR as a non-pharmacological adjuvant in post-THA care, the findings of this study will provide significant contributions to evidence-based nursing practices aimed at developing multimodal pain management strategies, reducing opioid consumption, and enhancing patient satisfaction.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for elective surgery who agree to participate in the study, * Individuals 18 years of age or older, * Those with adequate cognitive function, * Those who have not previously undergone total hip replacement surgery, * Those who volunteer to participate in the study and sign the informed consent form, * Patients with a pain score (on a scale of 1 to 10) of 4 or higher were included in the study. Exclusion Criteria: * Individuals under the age of 18, * Those previously diagnosed with a chronic pain syndrome (other than hip osteoarthritis), * Individuals with impaired cognitive function (severe psychiatric disorders), * Individuals who have previously undergone total hip replacement surgery, * Individuals with severe hearing or visual impairments, * Individuals with a history of opioid dependence, * Patients with a pain score (on a scale of 1 to 10) of 4 or lower were excluded from the study.
Contact & Investigator
OĞUZHAN ÇAĞLAR, MSc Std
PRINCIPAL INVESTIGATOR
Adiyaman University
Frequently Asked Questions
Who can join the NCT07689461 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Virtual Reality. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07689461 currently recruiting?
Yes, NCT07689461 is actively recruiting participants. Contact the research team at ocaglar@adiyaman.edu.tr for enrollment information.
Where is the NCT07689461 trial being conducted?
This trial is being conducted at Malatya, Turkey (Türkiye).
Who is sponsoring the NCT07689461 clinical trial?
NCT07689461 is sponsored by Adiyaman University. The principal investigator is OĞUZHAN ÇAĞLAR, MSc Std at Adiyaman University. The trial plans to enroll 80 participants.